International private equity investor Bridgepoint acquires a majority stake in PharmaZell from DPE Deutsche Private Equity and Maxburg Capital Partners. The parties have agreed not to disclose the purchase price.
PharmaZell is a leading independent manufacturer of pharmaceutical active ingredients (API) in the highly stable and specialized API market. The company has a diversified portfolio of more than 70 active ingredients and holds a leading position in the industry of products for the treatment of respiratory, inflammatory and liver diseases, which are favored by changing lifestyles. Many of the company’s products require special treatment procedures and/or technologies. PharmaZell, headquartered in Raubling (near Munich), operates four state-of-the-art production and R&D locations in Germany, Italy and India and employs more than 900 people worldwide.
Bridgepoint manages over 29 billion euros, which are provided by global investors. These include public and private pension funds, asset managers, family offices, independent authorities and insurance companies around the world.
Blättchen & Partner advised the management of PharmaZell as part of the sale with Prof. Dr. Alexander Götz.
About Blättchen & Partner
Blättchen & Partner regularly advises management teams from a wide range of companies and industries and has more than 20 years of expertise in advising and implementing management and employee participation programs.
With innovative financial strategies, Blättchen & Partner GmbH has been one of the leading corporate finance experts in Germany for more than 30 years. The Munich-based company specialises in advising on management participation programmes,IPOs, bonds, promissory note loans and the associated capital market support after the issue. Other areas of focus in the range of services are company investments and M&A transactions. More than 500 transactions are a testament to the company’s proven expertise. The growing interdisciplinary competence network, the high level of customer satisfaction and the large number of publications on important corporate finance topics reflect the recognised reputation of Blättchen & Partner GmbH.